Intradomain Allosteric Regulation of Soluble Epoxide Hydrolase by Its Substrates DOI Open Access

Shoji Matsumura,

A Shida,

Moeno Tsuchii

и другие.

International Journal of Molecular Sciences, Год журнала: 2024, Номер 25(24), С. 13496 - 13496

Опубликована: Дек. 17, 2024

Soluble epoxide hydrolase (sEH) is a bifunctional enzyme with activity in the C-terminal domain (C-EH) and lipid phosphate phosphatase N-terminal (N-phos). The C-EH hydrolyzes bioactive epoxy fatty acids such as epoxyeicosatrienoic acid (EET). N-phos phosphomonesters, including signaling molecules of lysophosphatidic (LPA). Here, we report that are reciprocally regulated by their respective substrates. Full-length sEH (sEH-FL) showed positive cooperativity toward substrate for each domain. Similar was found when truncated enzymes having only C- domains, sEH-C sEH-N, respectively, were used, suggesting an intra-domain nature cooperativity. In addition, LPA inhibited sEH-FL equally. Similarly, EET activity. Structural kinetic data suggest presence allosteric sites enzyme, which share binding EET. Thus, two activities its own other This mechanism may explain why has evolved to have different activities, possibly allows balance metabolism lipids.

Язык: Английский

Enhancing cancer immunotherapy via inhibition of soluble epoxide hydrolase DOI Creative Commons

Abigail G. Kelly,

Weicang Wang,

Eva Rothenberger

и другие.

Proceedings of the National Academy of Sciences, Год журнала: 2024, Номер 121(7)

Опубликована: Фев. 8, 2024

Cancer therapy, including immunotherapy, is inherently limited by chronic inflammation-induced tumorigenesis and toxicity within the tumor microenvironment. Thus, stimulating resolution of inflammation may enhance immunotherapy improve immune checkpoint inhibition (ICI). As epoxy-fatty acids (EpFAs) are degraded enzyme soluble epoxide hydrolase (sEH), sEH increases endogenous EpFA levels to promote cancer-associated inflammation. Here, we demonstrate that systemic treatment with ICI induces expression in multiple murine cancer models. Dietary omega-3 polyunsaturated fatty acid supplementation pharmacologic inhibition, both alone combination, significantly anti-tumor activity these Notably, pharmacological abrogation pathway or combination counter-regulates an ICI-induced pro-inflammatory pro-tumorigenic cytokine storm. modulating through dietary represent a unique strategy paradigm therapies.

Язык: Английский

Процитировано

14

Immunoregulatory mechanisms of the arachidonic acid pathway in cancer DOI Creative Commons
Maria Tredicine, Matteo Mucci, Antonio Recchiuti

и другие.

FEBS Letters, Год журнала: 2025, Номер unknown

Опубликована: Фев. 20, 2025

The arachidonic acid (AA) pathway promotes tumor progression by modulating the complex interactions between cancer and immune cells within microenvironment. In this Review, we summarize knowledge acquired thus far concerning intricate mechanisms through which eicosanoids either promote or suppress antitumor response. addition, will discuss impact of on how they affect responsiveness to immunotherapy, as well potential strategies for manipulating AA improve anticancer immunotherapy. Understanding molecular pathways underlying role played its metabolites in may contribute development more effective immunotherapies.

Язык: Английский

Процитировано

1

Harnessing Oxylipins and Inflammation Modulation for Prevention and Treatment of Colorectal Cancer DOI Open Access

Julius Gretschel,

Racha El Hage,

Ruirui Wang

и другие.

International Journal of Molecular Sciences, Год журнала: 2024, Номер 25(10), С. 5408 - 5408

Опубликована: Май 15, 2024

Colorectal cancer (CRC) is one of the most prevalent cancers worldwide, ranking as third malignant. The incidence CRC has been increasing with time, and it reported that Westernized diet lifestyle play a significant role in its higher rapid progression. intake high amounts omega-6 (n − 6) PUFAs low levels omega-3 3) an important chronic inflammation progression, which could be associated increase prevalence. Oxylipins generated from are bioactive lipid mediators have various functions, especially proliferation. Carcinogenesis often consequence inflammation, evidence shown particular involvement n 6 PUFA arachidonic acid-derived oxylipins CRC, further described this review. A deeper understanding metabolism by their modifying enzymes, pathways, corresponding may allow us to identify new approaches employ oxylipin-associated immunomodulation enhance immunotherapy cancer. This paper summarizes identified context initiation, development, metastasis CRC. We explore chemo-prevention strategies involve potential therapeutics.

Язык: Английский

Процитировано

3

Aspirin-triggered DHA metabolites inhibit angiogenesis DOI Creative Commons
Marianela Vara-Messler, Lucia Trevisi, Elisabetta Zulato

и другие.

Frontiers in Pharmacology, Год журнала: 2025, Номер 16

Опубликована: Фев. 25, 2025

Blood vessels supply oxygen, nutrients and provide gateways for immune surveillance. Since this network nourishes all tissues, vessel abnormalities contribute to many diseases, such as cancer. One of the potential targets Docosahexaenoic Acid (DHA) in cancer is suppressing angiogenesis, a process new blood formation within tumors. In addition, aspirin (ASA) has antineoplastic effects that may be mediated, at least part, by metabolites derived from acetylated COX-2. We aimed determining effect DHA well its using vitro vivo models. Endothelial cell (EC) proliferation, motility capillary-like tube were determined MTT, wound healing, Boyden Matrigel assays, respectively. angiogenesis was measured sponge model mice. The biosynthesis proresolving lipid mediators ECs LC-MS-MS. DHA, but not arachidonic acid (AA), concentrations consistent with those reached after fish oil supplementation, decreased EC migration time- concentration-dependent manner. Pretreatment ASA modulated already 24 h, while both longer incubation times without affecting viability. 17-hydroxy-DHA detected upon increased amounts observed combined treatment ASA, an increase associated synergic on migration. 17(R)-hydroxy-DHA (17R-HDHA), metabolite resulting COX-2 activity reduced presence 17R-HDHA, also formation. These results confirmed where 17R-HDHA or downstream 17RResolvinD1 able decrease microvessels density model. Overall, we demonstrated ASA-dependent acetylation showed antiangiogenic effects, possibly conversion hydroxylated derivatives.

Язык: Английский

Процитировано

0

A Comprehensive Analysis of Epoxide Hydrolase 2 (EPHX2) in Pan‐Cancer DOI Creative Commons

Weiquan Hu,

Xiaoli Ding,

Xiangsheng Wu

и другие.

Cancer Reports, Год журнала: 2025, Номер 8(3)

Опубликована: Март 1, 2025

ABSTRACT Background and Aims Epoxide hydrolase 2 (EPHX2) regulates lipid signaling across various metabolites by encoding soluble epoxide hydrolase. However, its mechanisms implications in human malignancies remain unknown. This research aimed to detail the prognostic landscape of EPHX2 pan‐cancer explore potential relationship with immune infiltration tumor microenvironment. Methods Herein, multiple bioinformatics tools were used comprehensively evaluate expression, diagnostic, significance roles microenvironment cancers. The underlying EPHX2‐associated pathways cancers investigated gene set variation analysis (GSVA). TIDE, GDSC, CTRP databases applied predict response immunotherapy sensitivity small molecule drugs. Furthermore, expression was also validated qPCR experiments cancer cell lines. Results Overall results revealed significant down‐regulation mRNA most tumors. Despite high predictive cancers, played a protective or detrimental effect distinct types proved be valuable diagnostic biomarker range types, particularly kidney renal clear carcinoma, cervical squamous endocervical adenocarcinoma. Genetic alterations 33 tumors investigated. significantly linked infiltrations (particularly tumor‐associated macrophages), mutation burden, microsatellite instability, modulators, immunotherapeutic biomarkers. Single‐cell sequencing GSVA highlighted relevance regulating cancer‐related biological processes, including cycle apoptosis. In this view, targeting EPHX2‐dependent could promising therapeutic strategy for immunotherapy. Conclusion may serve as molecular diagnosis prognosis become novel target

Язык: Английский

Процитировано

0

Optimization of D-amino acid oxidase and epoxide hydrolase through high-performance characterization for targeted cancer therapy in sustainable biocatalysis DOI
Huijun Yu, Siyi Li, Jingyang Liu

и другие.

International Journal of Biological Macromolecules, Год журнала: 2025, Номер unknown, С. 142784 - 142784

Опубликована: Апрель 1, 2025

Язык: Английский

Процитировано

0

Identification of high-affinity inhibitors for epoxide hydrolase 2 from repurposed drugs in Parkinson’s disease therapeutics DOI
Anas Shamsi, Moyad Shahwan,

Sohaib Naseem Khan

и другие.

Journal of Biomolecular Structure and Dynamics, Год журнала: 2025, Номер unknown, С. 1 - 12

Опубликована: Май 4, 2025

Parkinson's disease (PD) is a prevalent neurodegenerative disorder characterized by the loss of dopaminergic neurons in substantia nigra that leads to bradykinesia and rest tremors. While molecular mechanisms underlying PD are not fully understood, rising evidence shows neuroinflammation as key factor neuron damage. The soluble epoxide hydrolase (sEH) has appeared player associated with which represents itself promising drug target. Here, we employed structure-based virtual screening methodology using repurposed drugs from DrugBank database identify high-affinity potential inhibitors sEH. Results showed two hit molecules, Fluspirilene Penfluridol, demonstrated appreciable docking specificity toward sEH active site. These molecules exhibited favorable pharmacological properties formed critical interactions residues essential for activity. Further, all-atom dynamics (MD) simulations followed principal component analysis free energy landscape were carried out provide deeper insights into conformational stability interaction complex Penfluridol. simulation results indicated Penfluridol contributed stabilization its structure throughout MD trajectories 500 ns. findings collectively suggest hold development inhibitors, offer therapeutic implications combating other conditions.

Язык: Английский

Процитировано

0

Omega-3 Fatty Acids in Cancer: Insight into the Mechanism of Actions in Preclinical Cancer Models DOI
Asavari Joshi, Mahabaleshwar V. Hegde,

Sharad P. Adekar

и другие.

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

Potent soluble epoxide hydrolase inhibitors based on thiazole-5-carboxamide structure with imidazolidinone moiety as a secondary pharmacophore DOI
Deniz Lengerli,

Beyzanur Koç,

Paul M. Jordan

и другие.

Bioorganic Chemistry, Год журнала: 2025, Номер 163, С. 108644 - 108644

Опубликована: Май 29, 2025

Язык: Английский

Процитировано

0

Exploring the Unique Role of Specialized Pro-Resolving Mediators in Cancer Therapeutics DOI

Katherine Quinlivan,

Isabella Howard,

Franciska Southan

и другие.

Prostaglandins & Other Lipid Mediators, Год журнала: 2024, Номер unknown, С. 106944 - 106944

Опубликована: Дек. 1, 2024

Язык: Английский

Процитировано

2